
Coloplast's President and CEO Kristian Villumsen eyes global growth opportunities in Atos Medical, which the Danish medtech company has just acquired for DKK 16bn (USD 2.5bn).
Both companies look to benefit from the shared ownership, especially when it comes to the Chinese market, where Atos has a string of upcoming launches.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app